- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04333199
Timely Nudge About Lab Results to Increase myGeisinger Uptake
Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.
The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.
The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Pennsylvania
-
Danville, Pennsylvania, États-Unis, 17822
- Geisinger
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Geisinger patient for whom a lab was ordered within 30 days prior to email date
- Patient's lab test result released day before email date
Exclusion Criteria:
- Patient already enrolled in myGeisinger
- Patient has already declined myGeisinger
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Aucune intervention: Control
Patients do not receive an email
|
|
|
Expérimental: Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
|
Email
Email
|
|
Expérimental: Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view.
The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
|
Email
Email
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Délai: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
Délai: 1 week post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 week post-intervention
|
|
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
Délai: 1 week post-intervention
|
Email was opened (yes / no)
|
1 week post-intervention
|
|
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
Délai: 1 week post-intervention
|
Link / button to start the enrollment process was clicked (yes / no)
|
1 week post-intervention
|
|
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
Délai: 1 month post-intervention
|
Patient unsubscribed from these email communications (yes / no)
|
1 month post-intervention
|
|
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
Délai: 1 month post-intervention
|
Patient enrolled in myGeisinger (yes / no)
|
1 month post-intervention
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 2020-0316
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- ANALYTIC_CODE
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .